Added to YB: 2026-02-02
Pitch date: 2026-01-29
VENUSREM.NS [neutral]
Venus Remedies Limited
-2.5%
current return
Author Info
Nine One Capital is an India-focused investment manager. We are value-conscious investors in Indian listed companies. Our focus is on investing in small/mid-size companies and companies operating in cyclical sectors. Sign up for the newsletter.
Company Info
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology.
Market Cap
INR 10.5B
Pitch Price
INR 790.05
Price Target
N/A
Dividend
N/A
EV/EBITDA
7.80
P/E
13.75
EV/Sales
1.18
Sector
Pharmaceuticals
Category
value
Venus Remedies Q3 FY26 Result Update
VENUSREM.NS (earnings): Strong Q delivered >20% EBITDA margin (multi-quarter high), TTM PAT ₹76cr = 13x PE. Transformed from leveraged to net-cash position with improving ROE. Focus on higher-value products driving operating leverage. Innovation pipeline adds optionality. Compelling re-rating candidate.
Read full article (1 min)